518 related articles for article (PubMed ID: 16282517)
21. Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial.
Daniel DG; Potkin SG; Reeves KR; Swift RH; Harrigan EP
Psychopharmacology (Berl); 2001 May; 155(2):128-34. PubMed ID: 11401000
[TBL] [Abstract][Full Text] [Related]
22. Ketamine with and without midazolam for emergency department sedation in adults: a randomized controlled trial.
Sener S; Eken C; Schultz CH; Serinken M; Ozsarac M
Ann Emerg Med; 2011 Feb; 57(2):109-114.e2. PubMed ID: 20970888
[TBL] [Abstract][Full Text] [Related]
23. A randomized comparison of nitrous oxide plus hematoma block versus ketamine plus midazolam for emergency department forearm fracture reduction in children.
Luhmann JD; Schootman M; Luhmann SJ; Kennedy RM
Pediatrics; 2006 Oct; 118(4):e1078-86. PubMed ID: 16966390
[TBL] [Abstract][Full Text] [Related]
24. Rapid-acting IM ziprasidone in a psychiatric emergency service: a naturalistic study.
Preval H; Klotz SG; Southard R; Francis A
Gen Hosp Psychiatry; 2005; 27(2):140-4. PubMed ID: 15763126
[TBL] [Abstract][Full Text] [Related]
25. Rescue Sedation When Treating Acute Agitation in the Emergency Department With Intramuscular Antipsychotics.
Klein LR; Driver BE; Horton G; Scharber S; Martel ML; Cole JB
J Emerg Med; 2019 May; 56(5):484-490. PubMed ID: 30745194
[TBL] [Abstract][Full Text] [Related]
26. A randomized controlled trial on use of propofol alone versus propofol with midazolam, ketamine, and pentazocine "sedato-analgesic cocktail" for sedation during ERCP.
Ong WC; Santosh D; Lakhtakia S; Reddy DN
Endoscopy; 2007 Sep; 39(9):807-12. PubMed ID: 17703390
[TBL] [Abstract][Full Text] [Related]
27. Intramuscular ziprasidone: an effective agent for sedation of the agitated ED patient.
Fulton JA; Axelband J; Jacoby JL; Heller MB
Am J Emerg Med; 2006 Mar; 24(2):254-5. PubMed ID: 16490666
[No Abstract] [Full Text] [Related]
28. Single-dose ziprasidone associated with QT interval prolongation.
Witsil JC; Zell-Kanter M; Mycyk MB
Am J Emerg Med; 2012 Jun; 30(5):837.e1-2. PubMed ID: 21641143
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
[TBL] [Abstract][Full Text] [Related]
30. Droperidol vs. haloperidol in the initial management of acutely agitated patients.
Resnick M; Burton BT
J Clin Psychiatry; 1984 Jul; 45(7):298-9. PubMed ID: 6376480
[TBL] [Abstract][Full Text] [Related]
31. Intramuscular ziprasidone: influence of alcohol and benzodiazepines on vital signs in the emergency setting.
Wilson MP; MacDonald K; Vilke GM; Ronquillo L; Feifel D
J Emerg Med; 2013 Dec; 45(6):901-8. PubMed ID: 24071032
[TBL] [Abstract][Full Text] [Related]
32. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
Olié JP; Spina E; Murray S; Yang R
Int Clin Psychopharmacol; 2006 May; 21(3):143-51. PubMed ID: 16528136
[TBL] [Abstract][Full Text] [Related]
33. Intravenous midazolam-droperidol combination, droperidol or olanzapine monotherapy for methamphetamine-related acute agitation: subgroup analysis of a randomized controlled trial.
Yap CYL; Taylor DM; Knott JC; Taylor SE; Phillips GA; Karro J; Chan EW; Kong DCM; Castle DJ
Addiction; 2017 Jul; 112(7):1262-1269. PubMed ID: 28160494
[TBL] [Abstract][Full Text] [Related]
34. Early onset of antipsychotic response in the treatment of acutely agitated patients with psychotic disorders.
Agid O; Kapur S; Warrington L; Loebel A; Siu C
Schizophr Res; 2008 Jul; 102(1-3):241-8. PubMed ID: 18495436
[TBL] [Abstract][Full Text] [Related]
35. Intravenous ketamine for adult procedural sedation in the emergency department: a prospective cohort study.
Newton A; Fitton L
Emerg Med J; 2008 Aug; 25(8):498-501. PubMed ID: 18660398
[TBL] [Abstract][Full Text] [Related]
36. The efficacy of intravenous droperidol in the prehospital setting.
Rosen CL; Ratliff AF; Wolfe RE; Branney SW; Roe EJ; Pons PT
J Emerg Med; 1997; 15(1):13-7. PubMed ID: 9017481
[TBL] [Abstract][Full Text] [Related]
37. Antiemetics in the ED: a randomized controlled trial comparing 3 common agents.
Braude D; Soliz T; Crandall C; Hendey G; Andrews J; Weichenthal L
Am J Emerg Med; 2006 Mar; 24(2):177-82. PubMed ID: 16490647
[TBL] [Abstract][Full Text] [Related]
38. Transition from ziprasidone im to oral formulation in agitated patients with acute exacerbation of schizophrenia: an open trial.
Mautone A; Scarone S;
Pharmacopsychiatry; 2011 Jul; 44(5):173-8. PubMed ID: 21751127
[TBL] [Abstract][Full Text] [Related]
39. Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone.
Baldaçara L; Sanches M; Cordeiro DC; Jackoswski AP
Braz J Psychiatry; 2011 Mar; 33(1):30-9. PubMed ID: 21537720
[TBL] [Abstract][Full Text] [Related]
40. A Prospective Study of Intramuscular Droperidol or Olanzapine for Acute Agitation in the Emergency Department: A Natural Experiment Owing to Drug Shortages.
Cole JB; Stang JL; DeVries PA; Martel ML; Miner JR; Driver BE
Ann Emerg Med; 2021 Aug; 78(2):274-286. PubMed ID: 33846015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
